Nyxoah (NYXH) EBIT Margin (2021 - 2026)
Nyxoah's (NYXH) quarterly EBIT Margin came in at 57.47% in Q1 2026, down 638.0% year-on-year from 10.68% in Q1 2025, and up 100.01% quarter-over-quarter from 408938.51% in Q4 2025.
Nyxoah (NYXH) EBIT Margin (2021 - 2026) Analysis & Trends
Nyxoah's EBIT Margin history runs 6 years deep, the most recent figure standing at 57.47% for Q1 2026.
- On a quarterly basis, EBIT Margin fell 638.0% year-over-year to 57.47% in Q1 2026; TTM through Mar 2026 was 150493.94%, a 61270897.0% decrease from a year earlier, with the FY2025 full-year figure at 833.18%, up 47368.0% from the prior year.
- EBIT Margin grew to 57.47% in Q1 2026 per NYXH's latest filing, from 408938.51% in the prior quarter.
- Across five years, EBIT Margin topped out at 2654875343.76% in Q1 2023 and bottomed at 408938.51% in Q4 2025.
- The 5-year median for EBIT Margin is 1236.21% (2022), against an average of 195694700.16%.
- Across the five-year window, EBIT Margin soared 2000000000 bps in 2023 and tumbled 2000000000 bps in 2024, its largest moves.
- Year by year, EBIT Margin stood at 760.37% in 2022, then jumped by 88066186 bps to 669627253.18% in 2023, then slumped by 100 bps to 1636824.63% in 2024, then plunged by 125 bps to 408938.51% in 2025, then soared by 100 bps to 57.47% in 2026.
- Per Business Quant, the three latest NYXH EBIT Margin figures stand at 57.47% (Q1 2026), 408938.51% (Q4 2025), and 1226.88% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 98.77% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 33.60% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 1.97% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 5.74% |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 34.92% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 20.53% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -2.87% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 4.04% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 13.65% |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | 57.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57.47% |
| Dec 31, 2025 | -408,938.51% |
| Sep 30, 2025 | -1,226.88% |
| Jun 30, 2025 | 1,610.52% |
| Mar 31, 2025 | 63.85% |
| Dec 31, 2024 | 1,636,824.63% |
| Sep 30, 2024 | -12,106.79% |
| Jun 30, 2024 | 1,860.57% |
| Mar 31, 2024 | 1,078,768.71% |
| Dec 31, 2023 | 669,627,253.18% |
| Sep 30, 2023 | 1,256.76% |
| Jun 30, 2023 | 1,217.52% |
| Mar 31, 2023 | 2,654,875,343.76% |
| Dec 31, 2022 | 760.37% |
| Sep 30, 2022 | 5,001.65% |
| Jun 30, 2022 | 919.66% |
| Mar 31, 2022 | 1,236.21% |
| Dec 31, 2021 | 2,465,084,810.17% |
| Sep 30, 2021 | 4,006.90% |
| Jun 30, 2021 | -3,715.68% |